Today: 10 June 2026
Victoria’s Secret Stock Posts Record Session, Looks to What’s Next
3 June 2026
2 mins read

Victoria’s Secret Stock Posts Record Session, Looks to What’s Next

New York, June 3, 2026, 06:05 (EDT)

Victoria’s Secret & Co. shares slipped in early premarket Wednesday, cooling off after the stock jumped 47% and closed at a record on its first session with the new VSXY ticker.

The stock ended Tuesday at $80.06, gaining 47.44%. In premarket trading, shares were indicated at $77.78, down 2.85%. That came after the company posted a stronger quarter and raised its 2026 profit forecast sharply.

Victoria’s Secret switched its NYSE ticker to VSXY from VSCO on June 2, lining it up with its first-quarter results release. The company said the new symbol signals a stronger brand direction after years of mixed messaging.

Victoria’s Secret (VSCO) posted a 15% jump in first-quarter net sales to $1.560 billion, with comparable sales up 13%. Adjusted operating income came in at $80 million, beating the forecast range of $32 million to $42 million. The results raise the question for investors of whether CEO Hillary Super’s turnaround is shifting from hype to real earnings.

Super said it’s a “very strong start to 2026” and that the company is “increasingly confident” in its path. Chief Financial and Operating Officer Scott Sekella noted “higher regular-price selling” with fewer promotions, which is important for a retailer looking to boost margins away from discounting. Victoria’s Secret & Co.

Victoria’s Secret now sees full-year sales between $7.03 billion and $7.13 billion, up from the $6.85 billion to $6.95 billion it gave before. Adjusted operating income guidance also got bumped to a range of $550 million to $580 million from the earlier $430 million to $460 million. Second-quarter sales are expected at $1.590 billion to $1.615 billion.

Shares swung sharply. Reuters said the stock jumped to a record $81.28 on Tuesday. About 19% of the public float was sold short, so many traders had been betting against the stock. As those bets went wrong, short covering helped drive the surge, known as a short squeeze. Telsey Advisory’s Dana Telsey said the “leadership team and strategies are beginning to bear fruit.” Reuters

Goldman Sachs analyst Brooke Roach said the quarter was a “very strong result” and pointed to broad-based momentum. Goldman lifted its price target to $56 but stayed at Neutral. BofA Securities kept its Buy rating with a $68 target. BofA noted the 13% comparable-sales gain and better margins as signs the brand turnaround is making progress. Investing.com

UBS moved Victoria’s Secret down to Neutral from Buy, lifting its target to $90. UBS said the Buy call had mostly played out after four strong quarters for same-store sales. Jefferies also cut Victoria’s Secret to Hold from Buy, and took its target to $73, pointing to better recognition in the market for the turnaround.

Victoria’s Secret’s first-quarter beat puts the spotlight on other specialty-apparel names like Abercrombie & Fitch, American Eagle, and Gap. That’s its main peer set, based on the company’s proxy. The result increases pressure on those retailers to deliver growth without cutting into margins with more aggressive promotions.

U.S. stock-index futures hung near record levels early Wednesday. Oil prices pushed higher, Reuters said. The stock moved in premarket action ahead of the NYSE’s main session, which goes from 9:30 a.m. to 4:00 p.m. Eastern.

The risks are more obvious after a stock almost doubles in a single session. There’s just not as much space for letdowns. Victoria’s Secret has its own list of worries—tariffs, shaky consumer confidence, swings in the stock and activist shareholders. The company is also up against a proxy fight with BBRC International before the annual meeting on June 11.

Execution is the next hurdle. Investors are eyeing if bra sales, PINK, and Beauty keep pulling in shoppers at full price, and if second-quarter guidance stands up to any tariff hit or soft spending. Right now, the stock has moved to lower expectations quicker than the company has been able to show results for the full year.

Stock Market Today

  • LVMH Stock Slides After Rally; RBC Maintains Buy with €600 Target
    June 10, 2026, 5:21 AM EDT. LVMH shares dipped to €489.90 on Wednesday, retreating after a four-day rally amid a 24% decline since January. RBC reaffirmed its Buy rating and maintained a €600 price target, citing potential recovery tied to July's first-half results. Investors are focused on Fashion & Leather Goods, LVMH's largest segment, which saw a 2% organic revenue drop in Q1. Other divisions like Watches & Jewelry and Wines & Spirits showed positive growth gains. The company's market capitalization stands at approximately €244 billion. Despite recent volatility, RBC's outlook hinges on easing regional pressures, especially in the Middle East, and signs of revived brand momentum critical for stock value.

Latest articles

SoFi Stock Faces a Crucial Pre-Market Test as Wall Street Turns Defensive

10 June 2026
Rolls-Royce shares rebounded 1.5% in London after Tuesday’s 2.68% drop, as investors weighed fresh airline criticism over engine delays against the company’s reaffirmed 2026 profit and cash flow guidance; CEO Tufan Erginbilgic said Rolls had a “strong start to the year,” but risks remain if airline pressure leads to higher costs or slower cash conversion.
LVMH Drops Following Quick Rally, RBC Still Sees Recovery for Luxury

LVMH Drops Following Quick Rally, RBC Still Sees Recovery for Luxury

10 June 2026
LVMH shares slipped 0.49% to €489.90 in Paris after a four-day rebound, as investors weighed RBC’s reiterated Buy rating with a €600 target against ongoing 2026 losses and a 24% year-to-date drop; all eyes now turn to July’s first-half results for signs of recovery in Fashion & Leather Goods and any relief from Middle East weakness.
Roche Shares Edge Up After $2.3 Billion Nurix Cancer Pact

Roche Shares Edge Up After $2.3 Billion Nurix Cancer Pact

10 June 2026
Roche’s participation certificates climbed 1.07% to CHF 322.20 after announcing a $2.3 billion deal with Nurix Therapeutics for late-stage blood-cancer drug bexobrutideg, planned to enter Phase 3 trials this summer in CLL, as investors weigh the asset’s potential to offset losses from expiring patents and drive mid-single-digit sales growth in 2026.
YY Group Shares Jump Premarket on Humanoid Robot Move

YY Group Shares Jump Premarket on Humanoid Robot Move

10 June 2026
YYGH jumped to $0.19 in early pre-market after announcing deployment of Unitree G1 humanoid robots for facility management, aiming to turn operational know-how into higher-margin data assets, but the stock remains volatile near record lows after a recent reverse split and has not confirmed robot-driven revenue or margin gains.
Tencent Shares Gain After $4.66B Bond Sale Seen Fueling AI Bets

Tencent Shares Gain After $4.66B Bond Sale Seen Fueling AI Bets

10 June 2026
Tencent shares jumped 3.22% to HK$467.80 after the company priced a larger-than-expected US$4.66 billion dual-currency bond deal, drawing over US$17 billion in orders and allowing tighter pricing, as investors weighed Tencent’s ability to fund rising AI investments while maintaining strong cash flow and ongoing share buybacks.
Dow futures edge lower with oil up, markets watch Wall Street highs
Previous Story

Dow futures edge lower with oil up, markets watch Wall Street highs

Idaho Power Pushes for Two New Gas Plants; Customer Timeline Starts
Next Story

Idaho Power Pushes for Two New Gas Plants; Customer Timeline Starts

Go toTop